Stock Alert: Fulgent Up 12% On Getting EUA For Its Covid-19 Testing

Shares of Fulgent Genetics, Inc. (FLGT) are surging more than 12% Monday morning after the company announced that Fulgent Therapeutics, LLC, a unit of Fulgent Genetics received Emergency Use Authorization (EUA) from the FDA for its RT-PCR test for the detection of SARS-CoV-2 virus that causes Covid-19.

Fulgent stock is currently trading at $18.57, close to its 52 week high of 20.60.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
Swiss luxury goods group Compagnie Financiere Richemont AG reported Friday significantly higher profit in fiscal 2022 with strong growth in demand. The company also lifted its dividend, and announced a special dividend. Meanwhile, the shares were losing around 12 percent in the morning trading in Switzerland. Coeurd-Alene, Idaho-based White Cane Smoked Salmon LLC is recalling Wild Alaskan Cooked and Smoked Salmon as it contains undeclared wheat and soy, known allergens, the U.S. Food and Drug Administration said. The affected Alaskan Cooked and Smoked Salmon is packaged in vacuum bag, sold frozen, and there is no lot code or best by date on a package. Auto giant Ford Motor Co. (F) has issued a recall of about 39,000 2021 Expedition and Lincoln Navigator vehicles due to fire risk. The company has asked the customers of the recalled 2021 Ford Expedition and Lincoln Navigator SUVs to park their vehicles outside and away from structures while it investigates...
Follow RTT